These novel therapies , Semaglutide , represent a significant advancement in treating obesity and conceivably other conditions . These drugs are grouped as GLP-1 receptor activators , indicating they function to replicate the endogenous GLP-1 hormone , boosting glucose production and reducing food intake. While Retatrutide every functions somewh… Read More